Welcome to Coulter Partners Global (English)

28 April 2020

Top hires for VC & PE portfolio companies Q1-2020

Search Highlights

Recent top global hires for Venture Capital and Private Equity backed companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech.

This quarter’s successful placements include:

Function Focus area Location
CEO Antibody expression services Switzerland
Chief Technology Officer Diagnostics UK
Partner Life science consultancy US
Chief Scientific Officer Molecular genetic diagnostics Germany
Chief Medical Officer A.I. drug discovery UK
SVP Translational & Clinical Development Immunology US
Board Director Neurological diseases US
Chair Ophthalmology services Germany
Board Director Oncology & orphan diseases France
VP Manufacturing & Supply Chain Nephrology Netherlands
Head of Biology and Translational Sciences Oncology US
New Venture Lead Life science VC France
Head of Commercial Europe Digital health Australia
Corporate Counsel & VO Business Devt. Specialty pharma Netherlands

Newly opened projects include:

Function Focus area Location
CEO Medical devices Germany
Chief Commercial Officer (CEO Designate) Digital health UK
Head of Regulatory Affairs Drug delivery technologies & CRO Switzerland
2 roles: Chief Financial Officer and Chair Medical devices US
VP Finance Bioprinting technology & regenerative medicine Switzerland
Chief Scientific Officer Aesthetics US
VP Drug Discovery Immuno-oncology UK
Head of CMC Technical Operations Genomics US
Marketing Director APAC Medical devices Singapore
Digital Board Director Healthcare services Denmark
Board Director Oncology Singapore
General Manager Orthopaedics Medical implants France


A new version of Coulter Partners is available.